Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Clinical trial NCT00256126 · COMPLETED

Trial details

NCT number: NCT00256126
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Growth Hormone Deficiency Turner Syndrome

Start date: 2005-05-31
Primary completion: 2007-09-30
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.